Related Experiment Videos
Regulatory T cells and type 1 diabetes
Brygida C Bisikirska1, Kevan C Herold
1Division of Endocrinology, Naomi Berrie Diabetes Center, Department of Medicine, College of Physicians and Surgeons, Columbia University, Room 10-105, 630 W. 168th Street, New York, NY 10032, USA.
Current Diabetes Reports
|March 30, 2005
Summary
Regulatory T cells are crucial for self-tolerance and immune responses. Defects in these cells are observed in type 1 diabetes, suggesting potential for adoptive immune therapy.
Area of Science:
- Immunology
- Endocrinology
- Cell Biology
Background:
- Regulatory T cells (Tregs) are key players in maintaining self-tolerance.
- Tregs also influence responses to immunotherapies.
- Potential defects in Tregs are implicated in type 1 diabetes pathogenesis.
Purpose of the Study:
- To explore the role of regulatory T cells in self-tolerance and immune responses.
- To investigate the potential involvement of Treg defects in type 1 diabetes.
- To assess the feasibility of Treg expansion for adoptive immunotherapy.
Main Methods:
- Review of existing literature on regulatory T cell function.
- Analysis of studies investigating Treg populations in type 1 diabetes.
- Evaluation of immune therapy strategies for Treg expansion.
Main Results:
- Regulatory T cells are vital for preventing autoimmune reactions.
- Evidence suggests Treg dysfunction may contribute to type 1 diabetes.
- Immune therapies show promise in expanding regulatory T cells.
Conclusions:
- Regulatory T cells are critical for immune homeostasis.
- Targeting regulatory T cells offers a potential therapeutic avenue for type 1 diabetes.
- Adoptive transfer of expanded regulatory T cells could restore immune tolerance.